BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,605,031 | +4.6% | 791,671 | +4.0% | 1.70% | +2.5% |
| Q2 2023 | $5,356,764 | +11.2% | 760,904 | +31.7% | 1.66% | -16.7% |
| Q1 2023 | $4,818,493 | +54.2% | 577,757 | +112.3% | 1.99% | +122.5% |
| Q4 2022 | $3,124,546 | +32.9% | 272,173 | +45.9% | 0.89% | +12.5% |
| Q3 2022 | $2,351,000 | +315.4% | 186,603 | +248.7% | 0.80% | +356.9% |
| Q2 2022 | $566,000 | +187.3% | 53,521 | -47.7% | 0.17% | +112.2% |
| Q1 2022 | $197,000 | -76.0% | 102,425 | -6.9% | 0.08% | -82.8% |
| Q4 2020 | $820,000 | – | 110,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |